Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

NCT00463515

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: ZNA Middelheim Antwerp, Belgium

University Hospital Antwerp Edegem, Antwerp, Belgium

Sint Augustinus Ziekenhuis Wilrijk, Antwerp, Belgium

Completed

NCT00796796

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

Completed

NCT00022711

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +8 more
Locations: Hunterdon Regional Cancer Center Flemington, New Jersey, United States

Kimball Medical Center Lakewood, New Jersey, United States

South Jersey Regional Cancer Center Millville, New Jersey, United States

Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States

View all 17 locations

Completed

NCT00005091

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Helsinki University Central Hospital Helsinki, Finland

Thoraxklinik Rohrbach Heidelberg, Germany

Ospedale Bellaria Bologna, Italy

Academisch Ziekenhuis der Vrije Universiteit Amsterdam, Netherlands

Completed

NCT00003089

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations: Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States

Completed

NCT00002475

Conditions: Adenocarcinoma, Adenoma, Breast Cancer, +51 more
Locations: St. Vincent Medical Center - Los Angeles Los Angeles, California, United States

Completed

NCT00529100

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada

Completed

NCT00002852

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States